This HTML5 document contains 12 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Subject Item

n2:id

marcrel:aut

n4:id n5:id n7:id n9:id n10:id n12:id n13:id

dcterms:bibliographicCitation

DurierChristine, DesaintCorinne, CuzinLise, SurénaudMathieu, HéninYvette, LelièvreJean-Daniel, BonnetB, PialouxGilles, Poizot-MartinIsabelle, Ben HamoudaNadine, JacksonAngéla, FlysC, GuérinChristine, AboulkerJean-Pierre, ChoppinJeannine, LaunayOdile . OA04-01 . Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial . AIDS Vaccine 2009, Oct 2009, Paris, France . pp.O25, ⟨10.1186/1742-4690-6-S3-O25⟩ Durier Christine, Desaint Corinne, Cuzin Lise, Surénaud Mathieu, Hénin Yvette, Lelièvre Jean-Daniel, Bonnet B, Pialoux Gilles, Poizot-Martin Isabelle, Ben Hamouda Nadine, Jackson Angéla, Flys C, Guérin Christine, Aboulker Jean-Pierre, Choppin Jeannine, Launay Odile. OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial. AIDS Vaccine 2009, Oct 2009, Paris, France. pp.O25, ⟨10.1186/1742-4690-6-S3-O25⟩

dcterms:title

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

dc:date

2009

bibo:doi

10.1186/1742-4690-6-S3-O25